Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Ege Tıp DergisiOpen Access

A retrospective study on neuropsychiatric presentations of mucopolysaccharidoses

View Full Paper
Ask AI
Bookmark
Share

Authors

FEFehime ErdemEge UniversityHYHavva YazıcıEge UniversityMÇMerve Yoldaş ÇelikEge University

Discussion

Loading...

Member takes

Implication

Retrospective study reveals neuropsychiatric symptoms in mucopolysaccharidoses patients, suggesting early intervention is key.

Key Points

  • Mucopolysaccharidoses frequently cause neuropsychiatric symptoms, impacting cognitive and behavioral health.
  • Of 11 patients, 54.5% experienced speech delay, indicating significant communication challenges.
  • Diagnosis included various types of MPS, with MPS IIIA being the most common observed subtype among participants.
  • Prompt consideration of mucopolysaccharidoses is vital for early diagnosis and intervention in affected individuals.

Cite This Study

Erdem et al. (2025) studied this question.

synapsesocial.com/papers/68c199da9b7b07f3a061aefbhttps://doi.org/10.19161/etd.1540924
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial2018 · 48 citations
  2. 2Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial2018 · 159 citations
  3. 3Epilepsy in mucopolysaccharidosis disorders2017 · 39 citations
  4. 4Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases2019 · 28 citations